FDA Raises Concerns Over Children's COVID-19 Vaccine Safety

An internal memo from the U.S. Food and Drug Administration suggests that COVID-19 vaccinations may have led to the deaths of at least 10 children. The memo, citing myocarditis as a potential cause, was reported by the New York Times. Reuters has yet to verify these claims.


Devdiscourse News Desk | Updated: 29-11-2025 09:12 IST | Created: 29-11-2025 09:12 IST
FDA Raises Concerns Over Children's COVID-19 Vaccine Safety
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.

The U.S. Food and Drug Administration (FDA) expressed concerns in an internal memo about the safety of COVID-19 vaccinations for children. The memo indicated that at least 10 pediatric deaths might be linked to the vaccinations, with myocarditis listed as a possible cause, according to a report by the New York Times.

Despite the gravity of the information, Reuters has been unable to independently verify the accuracy of the FDA's claims, leaving questions about the true extent of the vaccine's side effects on children.

This development comes amidst ongoing debates over the safety and necessity of vaccinating children against COVID-19, highlighting the balancing act between public health measures and individual safety concerns.

(With inputs from agencies.)

Give Feedback